Home Program Speakers Organization Location Photos Contact

News

August 01, 2009

The website for the 2009 edition of the FiCE workshop is now available.

Contact

If you have any questions, comments and/or suggestions regarding the Frontiers in Computational Electrocardiology workshop, please do not hesitate to contact us.

Welcome!

Dear Colleagues,

You are kindly invited to attend the second edition of the workshop Frontiers in Computational Electrocardiology (FiCE 2009) that will take place in the historical heart of Maastricht, The Netherlands on October 1, 2009.

The FiCE 2009 workshop is jointly organized by the Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre and the Department of Knowledge Engineering, Maastricht University.

Computational techniques play an ever increasing role in the fields of Cardiology and Electrophysiology. In 2008 Maastricht University hosted the first edition of FiCE, a one-day workshop in which eminent and promising investigators from Europe and the United States presented their views on the current opportunities and future challenges of computer modeling in electrocardiology.

The focus of FiCE 2009 lies on electropharmacology and the speakers, which include clinicians, basic scientists and representatives from academia and industry from both The Netherlands and abroad, will discuss the possibilities and challenges of pharmacological interventions to alter and control the cardiac rhythm as well as illustrate how quantitative approaches can aid our understanding of pharmacological effects.

Apart from the workshop, a dinner is organized on the evening of October 1st, for which you can register. This social event creates an extra opportunity for interaction with the speakers and other participants of the workshop.

Registration for the workshop and/or the dinner is possible at the website Frontiers in Computational Electrocardiology (see registration page).

Please note that there are only a limited number of 70 seats available for the workshop. More information regarding the program, registration, and venue of the workshop can be found via the different links located at the top of this website.

We look forward to welcoming you in Maastricht on October 1,

The organizers,

Paul Volders and Ronald Westra

Paul G.A. Volders, MD, PhD
Department of Cardiology
Cardiovascular Research Institute Maastricht
Maastricht University Medical Centre
E-mail: p.volders@cardio.unimaas.nl

Ronald L. Westra, PhD
Department of Mathematics
Maastricht University
E-mail: westra@math.unimaas.nl

Maastricht University

Academic Hospital Maastricht

Cardiovascular Research Institute Maastricht

Program

All presentations will take place at Maastricht University (see location for more information). For the detailed program please refer to the program page

09:00	Registration

10:00	Word of welcome
	Martin Paul, MD, PhD Maastricht University / Maastricht University Medical Centre, The Netherlands

10:15	Introductory remarks
	Paul G.A. Volders, MD, PhD, Maastricht University Medical Centre, The Netherlands

10:20	Keynote lecture: Are cardiac ion channels good targets for developing antiarrhythmic drugs?
	Edward E. Carmeliet, MD, PhD, University of Leuven, Belgium

10:50	Session 1: Molecular Genetics and Pharmacology of Cardiac Ion Channels Chairs: Arthur van den Wijngaard, PhD, Maastricht University Medical Centre, The Netherlands and Dirk L. Ypey, PhD, Leiden University Medical Center / Nijmegen University, The Netherlands
	1. Connie R. Bezzina, PhD, Academic Medical Center, Amsterdam, The Netherlands
	2. Dirk J. Snyders, MD, PhD, University of Antwerp, Belgium
	3. Gudrun Antoons, PhD, University of Leuven, Belgium
	4. Eric Schulze-Bahr, MD, Hospital of the University of Münster, Germany

12:30	Lunch

14:15	Session 2: Action Potentials, Drug Effects and Modeling Chair: Paul G.A. Volders, MD, PhD Maastricht University Medical Centre, The Netherlands, and Ronald L. Westra, PhD, Maastricht University, The Netherlands
	1. Antonio Zaza, MD, University of Milano-Bicocca, Italy
	2. Daniel M. Johnson, BSc, Maastricht University, The Netherlands
	3. Jean-Pierre Valentin, PhD; Najah Abi-Gerges, PhD; Mark R. Davies, PhD, AstraZeneca, United Kingdom
	4. David J. Gallacher, PhD, Johnson & Johnson Pharmaceutical R&D, Belgium

16:00	Coffee / Tea

16:20	Session 3: AntiarrhythmicDrugs and Clinical Risk Profiling Chairs: Norbert M. van Hemel, MD, PhD, St. Antonius Hospital, Nieuwegein, The Netherlands and Anton P.M. Gorgels, MD, PhD, Maastricht University, The Netherlands
	1. Hein J.J. Wellens, MD, PhD, Cardiovascular Research Institute Maastricht, The Netherlands
	2. Vera H.M. Deneer, PhD, St. Antonius Hospital, Nieuwegein, The Netherlands
	3. Yoram Rudy, PhD, Washington University in St. Louis, USA

17:45	Drinks and dinner